145441-06-1 Usage
Uses
Used in Pharmaceutical Research and Development:
2,6-dimethylphenyl 5-methylisoxazole-3-carboxylate is used as a chemical intermediate for the synthesis of new drugs, leveraging its potential biological activity. Its unique structure and properties may contribute to the development of novel therapeutic agents.
Used in Biological Systems Studies:
In the field of biological research, 2,6-dimethylphenyl 5-methylisoxazole-3-carboxylate is used as a model compound to study the effects of isoxazole compounds on biological systems. This can provide insights into their interactions with biological molecules and potential applications in medicine.
Used in Drug Discovery:
2,6-dimethylphenyl 5-methylisoxazole-3-carboxylate is employed as a lead compound in drug discovery, where its structure and activity are optimized to develop effective pharmaceuticals. Its potential as a therapeutic agent is explored through various screening and optimization processes.
Check Digit Verification of cas no
The CAS Registry Mumber 145441-06-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,4,4 and 1 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 145441-06:
(8*1)+(7*4)+(6*5)+(5*4)+(4*4)+(3*1)+(2*0)+(1*6)=111
111 % 10 = 1
So 145441-06-1 is a valid CAS Registry Number.
145441-06-1Relevant academic research and scientific papers
New N-aryl isoxazolecarboxamides and N-isoxazolylbenzamides as anticonvulsant agents
Lepage,Tombret,Cuvier,Marivain,Gillardin
, p. 581 - 593 (2007/10/02)
We prepared a series of N-aryl isoxazolecarboxamide, N-isoxazolylbenzamide compounds and derivatives and studied their anticonvulsant action in MES and MMS tests. Some of these reveal considerable activity, especially with respect to MES test. The disubstitution in the 2.6-position on the phenyl ring by two methyl groups would appear to be of primary importance for the activity. The amide bridge between the phenyl and isoxazolic rings, whether of the anilide or benzamide type, seems to show similar anticonvulsant behavior. We have selected the derivatives 8 (N-(2.6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide, 12 (N-(2.6-dimethylphenyl)-5-hydroxymethyl-3-isoxazolecarboxamide) and 51 (N-(5-methyl-3-isoxazolyl)-2.6-dimethylbenzamide) which are presently being studied in more extended pharmacological tests.
